PUBLISHER: The Business Research Company | PRODUCT CODE: 1946628
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946628
Nuclear imaging devices and equipment play a crucial role in disease diagnosis, utilizing small amounts of radioactive substances administered to patients. They find extensive applications in various medical fields, including cardiology, obstetrics/gynecology, vascular studies, urology, and other medical applications.
The primary product categories within nuclear imaging devices and equipment include SPECT systems, PET systems, and planar scintigraphy. SPECT systems are employed to capture images and generate 3D scans, serving a range of applications such as oncology, cardiology, neurology, as well as other medical domains such as orthopedics, urology, thyroid-related disorders, and gastroenterology. These devices are utilized in diverse healthcare settings, including hospitals, imaging centers, academic and research institutes, as well as other end-users such as pharmaceutical/biotechnology companies and Contract Research Organizations (CROs).
Tariffs are influencing the nuclear imaging devices and equipment market by increasing costs of imported detectors, imaging electronics, gantry systems, and precision components. Hospitals and imaging centers in North America and Europe are most affected due to reliance on imported high-value imaging equipment, while Asia-Pacific faces cost pressure on system manufacturing and exports. These tariffs are increasing capital investment requirements and delaying system upgrades. However, they are also supporting local assembly, regional component sourcing, and domestic innovation in nuclear imaging technologies.
The nuclear imaging devices and equipment market research report is one of a series of new reports from The Business Research Company that provides nuclear imaging devices and equipment market statistics, including nuclear imaging devices and equipment industry global market size, regional shares, competitors with a nuclear imaging devices and equipment market share, detailed nuclear imaging devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear imaging devices and equipment industry. This nuclear imaging devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nuclear imaging devices and equipment market size has grown steadily in recent years. It will grow from $4 billion in 2025 to $4.13 billion in 2026 at a compound annual growth rate (CAGR) of 3.3%. The growth in the historic period can be attributed to growing incidence of chronic diseases, expansion of nuclear medicine departments in hospitals, increasing availability of radiotracers, adoption of advanced diagnostic imaging protocols, rising demand for early disease detection.
The nuclear imaging devices and equipment market size is expected to see steady growth in the next few years. It will grow to $4.71 billion in 2030 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to increasing investments in precision diagnostics, rising adoption of hybrid imaging technologies, expansion of nuclear cardiology and oncology imaging, growing focus on low-dose imaging solutions, increasing integration of ai-driven diagnostics. Major trends in the forecast period include increasing adoption of hybrid pet/ct and spect/ct systems, rising demand for advanced oncology imaging, growing integration of ai in image reconstruction, expansion of molecular imaging applications, enhanced focus on diagnostic accuracy and workflow efficiency.
The rising prevalence of chronic conditions is anticipated to drive the expansion of the nuclear imaging devices and equipment market in the coming years. Chronic conditions, also referred to as chronic diseases, are long-term medical issues that endure over an extended period, typically lasting three months or longer. Nuclear imaging devices and equipment facilitate the diagnosis and monitoring of chronic diseases by offering critical insights into disease progression, treatment effectiveness, and patient care. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that by 2050, over 35 million new cancer cases were expected, marking a 77% increase compared to the estimated 20 million cases in 2022. Consequently, the growing prevalence of chronic conditions is fueling the demand for nuclear imaging devices and equipment.
Major companies in the nuclear imaging devices and equipment market are increasingly investing in deep learning-based image processing solutions to improve diagnostic precision, lesion detectability, and operational efficiency. Deep learning, a branch of artificial intelligence, employs neural networks trained on extensive datasets to enhance image reconstruction, minimize noise, and enable accurate quantitative assessments. For example, in May 2023, GE HealthCare, a U.S.-based medical technology firm, obtained U.S. FDA 510(k) clearance for its Precision DL software, designed for its Omni Legend PET/CT system. This AI-driven solution provides, on average, an 11 % enhancement in contrast recovery, a 23 % increase in contrast-to-noise ratio, a 42 % improvement in detectability of small low-contrast lesions, and a 14 % gain in quantitative accuracy, thereby facilitating earlier detection and more confident clinical decision-making.
In April 2024, Spectrum Dynamics Medical, a US-based producer of nuclear imaging devices, formed a partnership with Hermes Medical Solutions to enhance nuclear medicine through integrated, vendor-neutral imaging solutions. The collaboration seeks to merge Hermes' Hermia software with Spectrum's VERITON-CT scanner, allowing advanced image processing, quantitative analysis, and theranostic dosimetry to optimize nuclear medicine workflows and elevate patient care. Hermes Medical Solutions is a Sweden-based medical software firm.
Major companies operating in the nuclear imaging devices and equipment market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Neusoft Medical Systems Co Ltd, Mediso Medical Imaging Systems Ltd, Digirad Corporation, CMR Naviscan Corporation, Shimadzu Corporation, Toshiba Medical Systems Corporation, DDD Diagnostics A/S, MILabs B.V., MR Solutions Ltd, SurgicEye GmbH, United Imaging Healthcare, Positron Corporation, Spectrum Dynamics Medical, Berthold Technologies GmbH & Co KG, Gamma Medica Inc, Cubresa Inc, PerkinElmer Inc
Western Europe was the largest region in nuclear imaging devices and equipment market in 2025. North America was the second-largest region in nuclear imaging devices and equipment market. The regions covered in the nuclear imaging devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the nuclear imaging devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The nuclear imaging devices and equipment market consist of sales of SPECT (single-photon emission computed tomography) systems, hybrid PET systems, and planar scintigraphy imaging systems. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nuclear Imaging Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses nuclear imaging devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for nuclear imaging devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nuclear imaging devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.